Last reviewed · How we verify
NCT03458689
Quadratus Lumborum Block Versus Transversus Abdominis Plane Block in Patients Undergoing Left Hemicolectomy
NA trial testing Left hemicolectomy, laparoscopic technique in Colon Neoplasm in 75 participants. Status unknown.
31 December 2020
Quick facts
| Lead sponsor | Ostfold Hospital Trust |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 75 |
| Start date | 28 February 2018 |
| Primary completion | 31 December 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Left hemicolectomy, laparoscopic technique
Conditions studied
- Colon Neoplasm — all drugs for Colon Neoplasm →
- Surgery — all drugs for Surgery →
- Pain, Postoperative — all drugs for Pain, Postoperative →
Sponsor
Ostfold Hospital Trust
Who can join
Adults 18 to 80, any sex, with Colon Neoplasm or Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The enhanced recovery after surgery and laparoscopic approach have been proven beneficial in surgery of the colon. However, patients have still pain, nausea and vomiting postoperatively. Postoperative pain is an expected but undesirable effect after an operation. This study will compare Transabdominis Plane (TAP) Block and Quadratus Lumborum (QL) Block with the common postoperative treatment with enteral and parenteral analgesics.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03458689
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colon Neoplasm
Currently open trials in the same condition.
- NCT07427537 — Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients · NA · recruiting
- NCT06652672 — Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma · NA · recruiting
- NCT06640166 — Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Co · Phase 2 · recruiting
- NCT07450612 — Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection · recruiting
- NCT05551052 — CRC Detection Reliable Assessment With Blood · active not recruiting
Other Ostfold Hospital Trust trials
Trials by the same sponsor.
- NCT07051915 — The Holistic Study · Phase 3 · not yet recruiting
- NCT05791630 — The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL) · NA · recruiting
- NCT06842446 — Systematic Machine Learning Algorithm for Rapid Thrombosis Detection · NA · recruiting
- NCT06568276 — The Benefit of Repairing the Deltoid Ligament in Unstable Ankle Fractures · NA · recruiting
- NCT05778916 — 5 Year Radiological and Clinical Results From Patients Operated for Hallux Valgus Deformity. · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03458689 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ostfold Hospital Trust
- Last refreshed: 13 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03458689.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing